Search Results - "Eleta, Martín"
-
1
Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer
Published in World journal of surgical oncology (30-11-2020)“…Nonoperative management after neoadjuvant treatment in low rectal cancer enables organ preservation and avoids surgical morbidity. Our aim is to compare…”
Get full text
Journal Article -
2
Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer
Published in Frontiers in oncology (07-01-2022)“…Rectal Cancer (RC) is a complex disease that involves highly variable treatment responses. Currently, there is a lack of reliable markers beyond TNM to deliver…”
Get full text
Journal Article -
3
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal Cancer
Published in Cancers (10-08-2020)“…Locally advanced rectal cancer (LARC) remains a medical challenge. Reliable biomarkers to predict which patients will significantly respond to neoadjuvant…”
Get full text
Journal Article -
4
A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma
Published in Translational oncology (01-06-2021)“…•High-risk HPV infection is less frequently detected in HIV-positive non-metastatic ASCC compared with HIV-negative cases.•Mutational profile identified in the…”
Get full text
Journal Article -
5
Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial
Published in Investigational new drugs (01-10-2020)“…Summary Purpose The vasopressin analog desmopressin (dDAVP) is known to increase plasma levels of hemostatic factors, and preclinical studies in colorectal…”
Get full text
Journal Article -
6
128: CAN DIFFERENT INTESTINAL TRANSPLANTATION SCENARIOS ALTER RADIOACTIVE TRACER UPTAKE IN A RODENT EXPERIMENTAL MODEL? A PRELIMINARY STUDY
Published in Transplantation (01-07-2023)Get full text
Journal Article -
7
Assessment of early response to imatinib 800 mg after 400 mg progression by .sup.18F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors
Published in Future oncology (London, England) (01-03-2015)“…ABSTRACT Introduction: Imatinib is the standard first-line therapy for advanced gastrointestinal stromal tumor. .sup.18 F-fluorodeoxyglucose PET computed…”
Get full text
Journal Article -
8
-
9
Assessment of early response to imatinib 800 mg after 400 mg progression by ^sup 18^F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors
Published in Future oncology (London, England) (01-03-2015)“…Introduction: Imatinib is the standard first-line therapy for advanced gastrointestinal stromal tumor. 18F-fluorodeoxyglucose PET computed tomography (FDG PET/…”
Get full text
Journal Article -
10
Assessment of early response to imatinib 800 mg after 400 mg progression by
Published in Future oncology (London, England) (01-03-2015)“…Imatinib is the standard first-line therapy for advanced gastrointestinal stromal tumor. F-fluorodeoxyglucose PET computed tomography (FDG PET/CT) shows a…”
Get full text
Journal Article -
11
Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors
Published in Future oncology (London, England) (2015)“…Imatinib is the standard first-line therapy for advanced gastrointestinal stromal tumor. (18)F-fluorodeoxyglucose PET computed tomography (FDG PET/CT) shows a…”
Get full text
Journal Article -
12
Experience of 1,000 patients
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 294 Background: The aim of this study is to present our experience between the correlation of 18 fluorocholine (FCH) positron emission tomography…”
Get full text
Journal Article -
13
Can we avoid radiotherapy with 18FCH PET/CT?
Published in Journal of clinical oncology (01-03-2019)“…Abstract only 282 Background: The aim of this study was to assess the utility of 18 fluorocholine (FCH) positron emission tomography (PET)/computed tomography…”
Get full text
Journal Article -
14
-
15
Moving foward and beyond the standard through a non-operative management in rectal cancer? Our watch and wait approach experience in Co-Recto
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
16
Still Awaiting That Waiting Be a Validated Affordable Option in Rectal Cancer? Our Watch and Wait Approach Experience in Co-Recto
Published in Annals of oncology (01-06-2014)Get full text
Journal Article -
17
P-0282 Facing Rectal Cancer Under the Age of 50: Analysis of 140 Patients Discussed in an Multidisciplinary Team (Co-Recto) in Argentina
Published in Annals of oncology (01-06-2012)Get full text
Journal Article -
18
Factors related to surgical complications and their impact on the functional status in 236 open surgeries for malignant tumors in a Latinoamerican hospital
Published in Surgical neurology (01-10-2007)“…Abstract Background There are not many studies that address the selection of patients harboring malignant brain tumors for open surgery. It is necessary,…”
Get full text
Journal Article -
19
Is one eye better than two in strabismus? Or does the misaligned amblyopic eye interfere with binocular vision? A preliminary functional MRI study
Published in Binocular vision & strabismus quarterly (2009)“…The aim of this study was to determine if patients with strabismic amblyopia could have increased occipital visual cortex activation with monocular stimulation…”
Get more information
Journal Article -
20
Superior oblique muscle MRI asymmetry and vertical deviation in patients with unilateral superior oblique palsy
Published in Binocular vision & strabismus quarterly (2006)“…To evaluate the MRI cross sectional greater area of the unilateral superior oblique (SO) muscle in patients with congenital or acquired superior oblique palsy…”
Get more information
Journal Article